Active	Status	Sponsor type	Region	Phase	Filter
5 Active 8 Inactive 13 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   - « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Salvecin (tosatoxumab) / Aridis
AR-301-002, NCT03816956 / 2017-004339-35: Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301	Completed	3	174	Europe, RoW	AR-301, AR-301 (tosatoxumab), Placebo	Aridis Pharmaceuticals, Inc.	Lung Infection, Pneumonia, Ventilator-Associated, Infection, Bacterial, Staphylococcus Aureus	10/22	10/22
9MW1411 / Mabwell (Shanghai) Biosci
NCT05339802: A Phase Ⅱ Clinical Study of 9MW1411 Injection in Acute Bacterial Skin and Skin Structure Infections	Recruiting	2	90	RoW	9MW1411 injection 1 combined with Linezolid, 9MW1411 injection 2 combined with Linezolid, 9MW1411 injection placebo combined with Linezolid	Mabwell (Shanghai) Bioscience Co., Ltd.	Skin Infection	10/23	12/23
TNM002 / Guangzhou Trinomab Biotechnology
NCT05664750: Study to Compare the Efficacy and Safety of Passive Immunization With TNM002 Injection and Human Tetanus Immunoglobulin as Prophylaxis Against Tetanus	Completed	3	675	RoW	TNM002, Human tetanus immunoglobulin (HTIG)	Zhuhai Trinomab Pharmaceutical Co., Ltd.	Tetanus	03/23	07/23
NCT05842798: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TNM002 in Chinese Healthy Adults	Completed	1	28	RoW	TNM002, Placebo	Trinomab Biotech Co., Ltd.	Healthy Volunteers	02/22	02/22
NCT06607380: A Randomized, Open-Label, Parallel-Design Pharmacokinetic and Pharmacodynamic Interaction Study of TNM002 and Adsorbed Tetanus Vaccine	Completed	1	60	RoW	TNM002, Adsorbed tetanus vaccine, TNM002 + adsorbed tetanus vaccine	Zhuhai Trinomab Pharmaceutical Co., Ltd.	Tetanus	04/23	04/23

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Salvecin (tosatoxumab) / Aridis
AR-301-002, NCT03816956 / 2017-004339-35: Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301	Completed	3	174	Europe, RoW	AR-301, AR-301 (tosatoxumab), Placebo	Aridis Pharmaceuticals, Inc.	Lung Infection, Pneumonia, Ventilator-Associated, Infection, Bacterial, Staphylococcus Aureus	10/22	10/22
9MW1411 / Mabwell (Shanghai) Biosci
NCT05339802: A Phase Ⅱ Clinical Study of 9MW1411 Injection in Acute Bacterial Skin and Skin Structure Infections	Recruiting	2	90	RoW	9MW1411 injection 1 combined with Linezolid, 9MW1411 injection 2 combined with Linezolid, 9MW1411 injection placebo combined with Linezolid	Mabwell (Shanghai) Bioscience Co., Ltd.	Skin Infection	10/23	12/23
TNM002 / Guangzhou Trinomab Biotechnology
NCT05664750: Study to Compare the Efficacy and Safety of Passive Immunization With TNM002 Injection and Human Tetanus Immunoglobulin as Prophylaxis Against Tetanus	Completed	3	675	RoW	TNM002, Human tetanus immunoglobulin (HTIG)	Zhuhai Trinomab Pharmaceutical Co., Ltd.	Tetanus	03/23	07/23
NCT05842798: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TNM002 in Chinese Healthy Adults	Completed	1	28	RoW	TNM002, Placebo	Trinomab Biotech Co., Ltd.	Healthy Volunteers	02/22	02/22
NCT06607380: A Randomized, Open-Label, Parallel-Design Pharmacokinetic and Pharmacodynamic Interaction Study of TNM002 and Adsorbed Tetanus Vaccine	Completed	1	60	RoW	TNM002, Adsorbed tetanus vaccine, TNM002 + adsorbed tetanus vaccine	Zhuhai Trinomab Pharmaceutical Co., Ltd.	Tetanus	04/23	04/23